EPCAM and adenocarcinoma: This is so because the sensitivity of BerEP4 for RCC is quite low.[9] Hence, the panel of immunocytochemistry utilized in differentiation of adenocarcinoma and mesothelial cells (BerEP4, B72.3 and calretinin) would not assist in the same distinction with regards to RCC.